🙂 Join a Webinair discussing SCA1: Join NAF next... - Ataxia UK

Ataxia UK

4,114 members•4,691 posts

🙂 Join a Webinair discussing SCA1

wobblybee profile image
wobblybee
•0 Replies

Join NAF next Thursday, May 4th at 12 pm CDT for our webinar series on SCA1. During this webinar, clinical expert Dr. Sharan Srinivasan will give us insight into the causes and symptoms of the disease, the typical diagnostic journey for those affected, & what to expect for clinical care. You may find this webinar helpful if you or a loved one has SCA1.

You can register here: us02web.zoom.us/webinar/reg...

Written by
wobblybee profile image
wobblybee
To view profiles and participate in discussions please or .

Not what you're looking for?

You may also like...

Join a remote Study for SCA1. SCA2. SCA3. or SCA6

A new remote study from the Harding Lab at Monash University aims to better understand how...
wobblybee profile image
•

Ataxia SCA1

Hi, just have a question-does anybody have the same problem. I was diagnosed with SCA1 in 2011, no...
Mirabella113 profile image
•

Another SCA1 cure being studied too slowly. PKA inhibitors.

So in my never ending quest to keep abreast of the research on cures for SCA1, I came across...
sunvox profile image
•

How did I miss this?? A real CURE for some genetic SCAs may be close!!!

By close I mean within a decade. Especially if you have SCA3 which is already in the pipeline for...
sunvox profile image
•

Finally crying "Uncle" and trying CoQ10. Who is taking Ubiquinol?

So for years I have resisted taking Ubiquinol because I believed it was similar in how it...
sunvox profile image
•

Moderation team

See all
HarryB profile image
HarryBAdministrator
VE93 profile image
VE93Administrator
WendyBom profile image
WendyBomModerator

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.